Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 3
1(33.3%)
Phase 2
1(33.3%)
3Total
N/A(1)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07492589Phase 2Recruiting

Photo-Acoustic and Ultrasonographic Mammoscope

Role: lead

NCT07483996Phase 3Not Yet Recruiting

Cryoablation Versus Lumpectomy in Early-Stage Breast Cancer

Role: lead

NCT06785506Recruiting

Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction

Role: collaborator

NCT05651724Recruiting

Global Research Initiative for Patients Screening on MASH

Role: collaborator

NCT06230458Not ApplicableRecruiting

Fractional Exhaled Nitric Oxide (FeNO)- Test as add-on Test in the Diagnostic Work-up of Asthma

Role: lead

All 5 trials loaded